Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124505364 | 12450536 | 4 | F | 20160901 | 20160609 | 20160915 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-117899 | RANBAXY | SHIGA Y, KANAYA Y, KONO R, TAKESHIMA S, SHIMOE Y, KURIYAMA M. DEMENTIA WITH LEWY BODIES PRESENTING MARKED TONGUE PROTRUSION AND BITE DUE TO LINGUAL DYSTONIA: A CASE REPORT. CLIN NEUROL. 2016;56(6):418-423 | 53.00 | YR | F | Y | 0.00000 | 20160915 | OT | GB | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124505364 | 12450536 | 1 | PS | Carbidopa / Levodopa | CARBIDOPALEVODOPA | 1 | Unknown | UNK | 78690 | ||||||||||
| 124505364 | 12450536 | 2 | SS | Carbidopa / Levodopa | CARBIDOPALEVODOPA | 1 | Unknown | UNK | 78690 | ||||||||||
| 124505364 | 12450536 | 3 | SS | Carbidopa / Levodopa | CARBIDOPALEVODOPA | 1 | Unknown | 200-300 MG | 78690 | ||||||||||
| 124505364 | 12450536 | 4 | SS | Carbidopa / Levodopa | CARBIDOPALEVODOPA | 1 | Unknown | UNK | Y | U | 78690 | ||||||||
| 124505364 | 12450536 | 5 | SS | ROPINIROLE. | ROPINIROLE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 124505364 | 12450536 | 6 | SS | ROPINIROLE. | ROPINIROLE | 1 | Unknown | UNK | Y | 0 | PROLONGED-RELEASE TABLET | ||||||||
| 124505364 | 12450536 | 7 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 5 - 10 MG | Y | 0 | |||||||||
| 124505364 | 12450536 | 8 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 5 - 10 MG | Y | 0 | |||||||||
| 124505364 | 12450536 | 9 | SS | QUETIAPINE. | QUETIAPINE | 1 | Unknown | UNK MG, UNK | Y | U | 0 | ||||||||
| 124505364 | 12450536 | 10 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | UNK MG, UNK | Y | U | 0 | ||||||||
| 124505364 | 12450536 | 11 | SS | ROTIGOTINE | ROTIGOTINE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 124505364 | 12450536 | 12 | C | Biperiden | BIPERIDEN | 1 | Unknown | 2 MG | 0 | ||||||||||
| 124505364 | 12450536 | 13 | C | Biperiden | BIPERIDEN | 1 | Unknown | 3 MG | 0 | ||||||||||
| 124505364 | 12450536 | 14 | C | BIPERIDEN | BIPERIDEN | 1 | Unknown | 6 MG | Y | 0 | |||||||||
| 124505364 | 12450536 | 15 | C | BROTIZOLAM | BROTIZOLAM | 1 | Unknown | .25 MG | U | 0 | |||||||||
| 124505364 | 12450536 | 16 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 1.5 MG | U | N | 0 | ||||||||
| 124505364 | 12450536 | 17 | C | PEROSPIRONE HYDROCHLORIDE | PEROSPIRONE HYDROCHLORIDE | 1 | Unknown | 8-16 MG | U | 0 | |||||||||
| 124505364 | 12450536 | 18 | C | TIAPRIDE HYDROCHLORIDE | TIAPRIDE HYDROCHLORIDE | 1 | Unknown | 50-150 MG | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124505364 | 12450536 | 1 | Dementia with Lewy bodies |
| 124505364 | 12450536 | 4 | Dementia with Lewy bodies |
| 124505364 | 12450536 | 5 | Dementia with Lewy bodies |
| 124505364 | 12450536 | 6 | Dementia with Lewy bodies |
| 124505364 | 12450536 | 7 | Product used for unknown indication |
| 124505364 | 12450536 | 9 | Product used for unknown indication |
| 124505364 | 12450536 | 10 | Product used for unknown indication |
| 124505364 | 12450536 | 11 | Product used for unknown indication |
| 124505364 | 12450536 | 12 | Parkinson's disease |
| 124505364 | 12450536 | 14 | Product used for unknown indication |
| 124505364 | 12450536 | 15 | Product used for unknown indication |
| 124505364 | 12450536 | 16 | Product used for unknown indication |
| 124505364 | 12450536 | 17 | Product used for unknown indication |
| 124505364 | 12450536 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124505364 | 12450536 | OT |
| 124505364 | 12450536 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124505364 | 12450536 | Altered state of consciousness | |
| 124505364 | 12450536 | Condition aggravated | |
| 124505364 | 12450536 | Drug hypersensitivity | |
| 124505364 | 12450536 | Drug interaction | |
| 124505364 | 12450536 | Dyskinesia | |
| 124505364 | 12450536 | Oromandibular dystonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124505364 | 12450536 | 2 | 201309 | 0 | ||
| 124505364 | 12450536 | 3 | 2013 | 0 | ||
| 124505364 | 12450536 | 4 | 201405 | 0 | ||
| 124505364 | 12450536 | 5 | 201411 | 0 | ||
| 124505364 | 12450536 | 6 | 201411 | 0 | ||
| 124505364 | 12450536 | 8 | 2013 | 0 | ||
| 124505364 | 12450536 | 11 | 2014 | 0 | ||
| 124505364 | 12450536 | 14 | 2013 | 0 | ||
| 124505364 | 12450536 | 17 | 2013 | 0 | ||
| 124505364 | 12450536 | 18 | 2013 | 0 |